Related Experiment Video
Updated: Jul 10, 2026

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
Application of liver stem cells for cell therapy
Malcolm R Alison1, Cleo Choong, Susan Lim
1Centre for Diabetes and Metabolic Medicine, Queen Mary's School of Medicine and Dentistry, ICMS, 4 Newark Street, London E1 2AT, UK. m.alison@qmul.ac.uk
The global donor liver shortage drives research into alternative cell therapies for liver disease. Stem cells and progenitor cells show promise for liver regeneration and support, though clinical application challenges remain.
Area of Science:
- Hepatology
- Regenerative Medicine
- Transplantation Biology
Background:
- The critical shortage of donor livers necessitates alternative treatments for end-stage liver disease.
- Current hepatocyte transplantation methods face challenges in achieving effective liver repopulation in humans.
- Emerging cell-based therapies aim to restore liver function and address unmet clinical needs.
Purpose of the Study:
- To review current and potential cell therapies for liver disease, focusing on stem cells, progenitor cells, and bone marrow.
- To evaluate the efficacy and challenges associated with different cell types in preclinical and early clinical settings.
- To identify strategies for improving cell transplantation success in liver regeneration.
Main Methods:
- Review of existing literature on embryonic stem cells, fetal/adult hepatocytes, hepatic progenitor cells, and bone marrow transplantation for liver disease.
- Analysis of animal model studies demonstrating the potential of cell therapies in improving liver function.
- Examination of early-phase clinical trial data for bone marrow transplantation in cirrhotic patients.
Main Results:
- Embryonic stem cells can differentiate into hepatocytes, showing promise in animal models without teratoma formation.
- Strategies enhancing transplanted hepatocyte survival and proliferation have shown success in animal models.
- While hepatic progenitor cell activation is crucial for acute liver failure, transplantation progress is limited.
- Autologous bone marrow transplantation has yielded moderately encouraging results in small phase 1 studies for cirrhosis.
Conclusions:
- Cell-based therapies, including stem cells and progenitor cells, offer potential alternatives to liver transplantation.
- Overcoming challenges in clinical cell engraftment and repopulation is essential for therapeutic success.
- Further research and clinical trials are needed to validate the safety and efficacy of these novel liver regeneration strategies.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
iPS Cell Differentiation
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Induced Pluripotent Stem Cells
Tissue Renewal without Stem Cells
However, failure of such a system...

